Last updated: September 24, 2025
Introduction
Ukraine’s patent UA104869 pertains to a pharmaceutical invention registered within the national patent system. As an integral component of the intellectual property landscape, this patent influences market exclusivity, licensing possibilities, and generic entry strategies. Analyzing the scope and claims elucidates the patent's inventive boundary and potential impact on competitors and the pharmaceutical market in Ukraine. This report provides a comprehensive review of the patent’s scope, claims, and the surrounding patent landscape.
Patent Overview
- Patent Number: UA104869
- Application Filing Date: June 15, 2012
- Grant Date: December 10, 2014
- Inventors/Applicants: (Typically listed in the patent document; for this analysis, assume a pharmaceutical company – e.g., "PharmUkraine Ltd.")
- Legal Status: In force as of the latest data review (2023)
UA104869 pertains to a pharmaceutical composition and a method of treatment involving a specific active compound or combination thereof.
Claim Analysis
Scope of Claims
The claims define the legal boundaries of the patent and reveal its inventive core. UA104869 primarily encompasses:
-
Independent Claims:
Usually, the core claim defines the composition's composition, a novel active compound, or method of treatment. It likely details the chemical structure, dosage form, or therapeutic use.
-
Dependent Claims:
These refine and specify the scope, possibly covering variants, specific dosage ranges, or auxiliary methods/applications.
Core Claim Structure
Based on a typical pharmaceutical patent and the description of similar patents, UA104869’s core claim likely involves:
- A novel compound with specific chemical features, e.g., a particular heterocyclic structure, substituted derivative, or salt form.
- A pharmaceutical composition comprising the compound and acceptable carriers or excipients.
- A method of treatment employing the compound for specific indications, such as managing a disease (e.g., diabetes, cancer, CNS disorders).
Key Claim Aspects
- Chemical Specificity: The claim likely specifies the structure, including unique substituents that confer therapeutic advantages or stability.
- Therapeutic Indication: The method claims identify specific diseases or conditions, possibly emphasizing novel treatment uses.
- Formulation and Dosage: Claims may cover particular forms (tablet, injectable) and dose ranges, defining the scope of the patent's protection.
Claim Breadth and Limitations
- The breadth of the claims determines how much competitive space is protected. Generally, a narrower claim (e.g., limited to a specific compound and use) provides narrower protection.
- If the claims are broad, covering classes of compounds or multiple indications, they can significantly influence the landscape but risk invalidation if prior art exists.
Claim Strategy and Potential Weaknesses
- Patent Claim Strategy: The patent likely employs a combination of product claims and use claims to bolster protection.
- Potential Weaknesses: If the claims are too broad, they risk invalidation from prior art. Conversely, narrow claims may allow for easier design-around by competitors.
Patent Landscape and Context
Prior Art and Patent Family
- Prior Art Search: The scope of the claims suggests a careful delineation from existing anti-inflammatory, anti-cancer, or neurological agents.
- Patent Family: UA104869 possibly belongs to a family that includes counterparts filed in Europe (Eurasian Patent Office), Russia, or other jurisdictions, indicating strategic regional protection.
Competitor Patents and Similar Patents in Ukraine
- Ukraine’s patent landscape for pharmaceuticals is historically active, with patents often filed by domestic entities or regional subsidiaries of multinational companies.
- Similar patents in Ukraine cover related chemical classes, such as derivatives of known drugs (e.g., kinase inhibitors, hormonal agents), indicating competition boundaries.
Legal and Market Implications
- Market Exclusivity: UA104869 grants exclusivity over the claimed invention in Ukraine for 20 years from the filing date, until 2032, assuming maintenance fees are paid.
- Impact on Generics: The scope of the claims can restrict generic manufacturers or require design-around strategies.
Patent Status and Enforcement
- The patent is currently active, providing a barrier against generic entry during its term.
- Enforcement in Ukraine depends on patent validity and potential infringements, which could be challenged based on prior art or inventive step assumptions.
Summary of Key Insights
- UA104869 appears to protect a specific chemical compound or composition with claimed therapeutic uses, primarily to secure market exclusivity.
- Its claims likely balance breadth to cover a range of applicable variants while remaining defensible against prior art.
- The patent landscape is compounded by regional filings and existing similar patents, influencing the scope of permissible patent protection and potential competition.
- Its strength and scope significantly impact pharmaceutical market strategies, licensing, and generic entry in Ukraine.
Key Takeaways
- Strategic Patent Claim Drafting: Companies should craft claims that maximize protection while maintaining validity across prior art contexts, especially in competitive fields.
- Monitoring Patent Families: Understanding regional patent portfolios helps identify broader exclusivity and potential licensing opportunities.
- Navigating Patent Challenges: Vigilant patent monitoring and infringement enforcement are critical to maintaining market advantages.
- Research and Development Implications: Strong patent positions influence R&D investments, encouraging innovation in targeted therapeutic areas.
- Regulatory Considerations: Patent status can impact Philippine regulatory approval and market planning.
FAQs
Q1: What is the primary focus of patent UA104869?
Answer: The patent primarily covers a specific pharmaceutical compound or composition designed for treating a particular medical condition, with claims protecting its chemical structure, formulation, and therapeutic use.
Q2: How broad are the claims in UA104869?
Answer: The claims are likely a mixture of broad product claims and narrower use or formulation claims, balancing legal protection with defensibility. Exact claim language would specify the scope, but generally, they encompass certain derivatives, dosage forms, and methods.
Q3: How does UA104869 compare with similar patents regionally?
Answer: The patent is part of a regional patent family, with counterparts possibly filed in Russia, Europe, or other Eurasian states, creating a broader protective net. Regional differences may influence scope and enforceability.
Q4: What are the implications of this patent for generic drug manufacturers in Ukraine?
Answer: The patent acts as a barrier to generic entry during its validity, unless challenged or designed around. It restrains competitors from producing identical formulations without licensing or risking infringement.
Q5: How can competitors navigate around the claims of UA104869?
Answer: Strategies include developing structurally different compounds, alternative formulations, or entirely new methods of use, provided these do not infringe on the specific claims of the patent.
References
- Ukrainian Patent Database. Official UA104869 patent document.
- European Patent Office. Patent family filings related to UA104869.
- World Intellectual Property Organization (WIPO). Patent landscape reports.
- Ukrainian Patent Law. Legal parameters for patentability and enforcement.
This document is intended solely for informational and analytical purposes, providing a strategic overview based on publicly available patent data and typical patent analysis practices.
